APO RESEARCH · REPORT
10-Deacetylbaccatin III
10-Deacetylbaccatin III is a taxane-scaffold chemical supplied as an identified research or manufacturing input.
Product & engineering
Understand the product.
This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
Chemical identity, substitution pattern, assay and related impurities define the supplied material. The named chemical category does not establish a finished formulation’s compatibility, end-use approval or performance; those depend on the actual grade and application.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 10-Deacetylbaccatin III?
Chemical identity, substitution pattern, assay and related impurities define the supplied material. The named chemical category does not establish a finished formulation’s compatibility, end-use approval or performance; those depend on the actual grade and application.
Technical reading
Selected research
Industry Research
10-Deacetylbaccatin III Industry Research Report 2026
Market perspective
This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
Global 10-Deacetylbaccatin III key players include SM Herbals, Alchem International, Indena, etc. Global top three manufacturers hold a share over 50%.
China is the largest market, with a share over 35%, followed by United States and Europe, both have a share over 50 percent.
Read the full market overview
In terms of product, ≥98.0% is the largest segment, with a share over 85%. And in terms of application, the largest application is Production of Docetaxel, followed by Production of Paclitaxel, etc.
Report Scope
This report quantifies the global 10-Deacetylbaccatin III market in revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to 10-Deacetylbaccatin III.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
10-Deacetylbaccatin III Market by Company
SM Herbals
Alchem International
Indena
South Pharmaceutical
HAOXUAN
Yuannan Hande
Sai Phytoceuticals
Sarv Biolabs Pvt
Aphios
Hainan Yew Pharmaceutical
10-Deacetylbaccatin III Segment by Type
Above 95%
Above 98.0%
Others
10-Deacetylbaccatin III Segment by Application
Production of Docetaxel
Production of Paclitaxel
Others
10-Deacetylbaccatin III Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10-Deacetylbaccatin III market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 10-Deacetylbaccatin III and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10-Deacetylbaccatin III.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of 10-Deacetylbaccatin III manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of 10-Deacetylbaccatin III by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of 10-Deacetylbaccatin III in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 95%
- Above 98.0%
- Others
Applications
- Production of Docetaxel
- Production of Paclitaxel
- Others
Companies covered
- SM Herbals
- Alchem International
- Indena
- South Pharmaceutical
- HAOXUAN
- Yuannan Hande
- Sai Phytoceuticals
- Sarv Biolabs Pvt
- Aphios
- Hainan Yew Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 10-Deacetylbaccatin III by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Above 95%
- 2.2.3 Above 98.0%
- 2.2.4 Others
- 2.3 10-Deacetylbaccatin III by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Production of Docetaxel
- 2.3.3 Production of Paclitaxel
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global 10-Deacetylbaccatin III Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global 10-Deacetylbaccatin III Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global 10-Deacetylbaccatin III Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global 10-Deacetylbaccatin III Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global 10-Deacetylbaccatin III Production by Manufacturers (2021-2026)
- 3.2 Global 10-Deacetylbaccatin III Production Value by Manufacturers (2021-2026)
- 3.3 Global 10-Deacetylbaccatin III Average Price by Manufacturers (2021-2026)
- 3.4 Global 10-Deacetylbaccatin III Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 10-Deacetylbaccatin III Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global 10-Deacetylbaccatin III Manufacturers, Product Type & Application
- 3.7 Global 10-Deacetylbaccatin III Manufacturers Established Date
- 3.8 Global 10-Deacetylbaccatin III Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 SM Herbals
- 4.1.1 SM Herbals 10-Deacetylbaccatin III Company Information
- 4.1.2 SM Herbals 10-Deacetylbaccatin III Business Overview
- 4.1.3 SM Herbals 10-Deacetylbaccatin III Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 SM Herbals Product Portfolio
- 4.1.5 SM Herbals Recent Developments
- 4.2 Alchem International
- 4.2.1 Alchem International 10-Deacetylbaccatin III Company Information
- 4.2.2 Alchem International 10-Deacetylbaccatin III Business Overview
- 4.2.3 Alchem International 10-Deacetylbaccatin III Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Alchem International Product Portfolio
- 4.2.5 Alchem International Recent Developments
- 4.3 Indena
- 4.3.1 Indena 10-Deacetylbaccatin III Company Information
- 4.3.2 Indena 10-Deacetylbaccatin III Business Overview
- 4.3.3 Indena 10-Deacetylbaccatin III Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Indena Product Portfolio
- 4.3.5 Indena Recent Developments
- 4.4 South Pharmaceutical
- 4.4.1 South Pharmaceutical 10-Deacetylbaccatin III Company Information
- 4.4.2 South Pharmaceutical 10-Deacetylbaccatin III Business Overview
- 4.4.3 South Pharmaceutical 10-Deacetylbaccatin III Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 South Pharmaceutical Product Portfolio
- 4.4.5 South Pharmaceutical Recent Developments
- 4.5 HAOXUAN
- 4.5.1 HAOXUAN 10-Deacetylbaccatin III Company Information
- 4.5.2 HAOXUAN 10-Deacetylbaccatin III Business Overview
- 4.5.3 HAOXUAN 10-Deacetylbaccatin III Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 HAOXUAN Product Portfolio
- 4.5.5 HAOXUAN Recent Developments
- 4.6 Yuannan Hande
- 4.6.1 Yuannan Hande 10-Deacetylbaccatin III Company Information
- 4.6.2 Yuannan Hande 10-Deacetylbaccatin III Business Overview
- 4.6.3 Yuannan Hande 10-Deacetylbaccatin III Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Yuannan Hande Product Portfolio
- 4.6.5 Yuannan Hande Recent Developments
- 4.7 Sai Phytoceuticals
- 4.7.1 Sai Phytoceuticals 10-Deacetylbaccatin III Company Information
- 4.7.2 Sai Phytoceuticals 10-Deacetylbaccatin III Business Overview
- 4.7.3 Sai Phytoceuticals 10-Deacetylbaccatin III Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Sai Phytoceuticals Product Portfolio
- 4.7.5 Sai Phytoceuticals Recent Developments
- 4.8 Sarv Biolabs Pvt
- 4.8.1 Sarv Biolabs Pvt 10-Deacetylbaccatin III Company Information
- 4.8.2 Sarv Biolabs Pvt 10-Deacetylbaccatin III Business Overview
- 4.8.3 Sarv Biolabs Pvt 10-Deacetylbaccatin III Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Sarv Biolabs Pvt Product Portfolio
- 4.8.5 Sarv Biolabs Pvt Recent Developments
- 4.9 Aphios
- 4.9.1 Aphios 10-Deacetylbaccatin III Company Information
- 4.9.2 Aphios 10-Deacetylbaccatin III Business Overview
- 4.9.3 Aphios 10-Deacetylbaccatin III Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Aphios Product Portfolio
- 4.9.5 Aphios Recent Developments
- 4.10 Hainan Yew Pharmaceutical
- 4.10.1 Hainan Yew Pharmaceutical 10-Deacetylbaccatin III Company Information
- 4.10.2 Hainan Yew Pharmaceutical 10-Deacetylbaccatin III Business Overview
- 4.10.3 Hainan Yew Pharmaceutical 10-Deacetylbaccatin III Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Hainan Yew Pharmaceutical Product Portfolio
- 4.10.5 Hainan Yew Pharmaceutical Recent Developments
5 Global 10-Deacetylbaccatin III Production by Region
- 5.1 Global 10-Deacetylbaccatin III Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global 10-Deacetylbaccatin III Production by Region: 2021-2032
- 5.2.1 Global 10-Deacetylbaccatin III Production by Region: 2021-2026
- 5.2.2 Global 10-Deacetylbaccatin III Production Forecast by Region (2027-2032)
- 5.3 Global 10-Deacetylbaccatin III Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global 10-Deacetylbaccatin III Production Value by Region: 2021-2032
- 5.4.1 Global 10-Deacetylbaccatin III Production Value by Region: 2021-2026
- 5.4.2 Global 10-Deacetylbaccatin III Production Value Forecast by Region (2027-2032)
- 5.5 Global 10-Deacetylbaccatin III Market Price Analysis by Region (2021-2026)
- 5.6 Global 10-Deacetylbaccatin III Production and Value, YOY Growth
- 5.6.1 North America 10-Deacetylbaccatin III Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe 10-Deacetylbaccatin III Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China 10-Deacetylbaccatin III Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan 10-Deacetylbaccatin III Production Value Estimates and Forecasts (2021-2032)
6 Global 10-Deacetylbaccatin III Consumption by Region
- 6.1 Global 10-Deacetylbaccatin III Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global 10-Deacetylbaccatin III Consumption by Region (2021-2032)
- 6.2.1 Global 10-Deacetylbaccatin III Consumption by Region: 2021-2026
- 6.2.2 Global 10-Deacetylbaccatin III Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America 10-Deacetylbaccatin III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America 10-Deacetylbaccatin III Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe 10-Deacetylbaccatin III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe 10-Deacetylbaccatin III Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific 10-Deacetylbaccatin III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific 10-Deacetylbaccatin III Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa 10-Deacetylbaccatin III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa 10-Deacetylbaccatin III Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global 10-Deacetylbaccatin III Production by Type (2021-2032)
- 7.1.1 Global 10-Deacetylbaccatin III Production by Type (2021-2032) & (kg)
- 7.1.2 Global 10-Deacetylbaccatin III Production Market Share by Type (2021-2032)
- 7.2 Global 10-Deacetylbaccatin III Production Value by Type (2021-2032)
- 7.2.1 Global 10-Deacetylbaccatin III Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global 10-Deacetylbaccatin III Production Value Market Share by Type (2021-2032)
- 7.3 Global 10-Deacetylbaccatin III Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global 10-Deacetylbaccatin III Production by Application (2021-2032)
- 8.1.1 Global 10-Deacetylbaccatin III Production by Application (2021-2032) & (kg)
- 8.1.2 Global 10-Deacetylbaccatin III Production Market Share by Application (2021-2032)
- 8.2 Global 10-Deacetylbaccatin III Production Value by Application (2021-2032)
- 8.2.1 Global 10-Deacetylbaccatin III Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global 10-Deacetylbaccatin III Production Value Market Share by Application (2021-2032)
- 8.3 Global 10-Deacetylbaccatin III Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 10-Deacetylbaccatin III Value Chain Analysis
- 9.1.1 10-Deacetylbaccatin III Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 10-Deacetylbaccatin III Production Mode & Process
- 9.2 10-Deacetylbaccatin III Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 10-Deacetylbaccatin III Distributors
- 9.2.3 10-Deacetylbaccatin III Customers
10 Global 10-Deacetylbaccatin III Analyzing Market Dynamics
- 10.1 10-Deacetylbaccatin III Industry Trends
- 10.2 10-Deacetylbaccatin III Industry Drivers
- 10.3 10-Deacetylbaccatin III Industry Opportunities and Challenges
- 10.4 10-Deacetylbaccatin III Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst